Strategic Partnerships & Business Development Manager, HeartFlow

$160-195k

+ Bonus

Senior and Expert level
San Francisco Bay Area

More information about location

3+ days a week in office (Rohnert Park, CA)

HeartFlow

Medical equipment manufacturing

Open for applications

HeartFlow

Medical equipment manufacturing

501-1000 employees

RetailB2BArtificial IntelligenceManufacturingDeep TechData AnalysisMedTech

Open for applications

$160-195k

+ Bonus

Senior and Expert level
San Francisco Bay Area

More information about location

3+ days a week in office (Rohnert Park, CA)

501-1000 employees

RetailB2BArtificial IntelligenceManufacturingDeep TechData AnalysisMedTech

Company mission

To establish a new era of personalized care by delivering AI-driven analysis and insights to proactively manage CAD for life.

Company mission

To establish a new era of personalized care by delivering AI-driven analysis and insights to proactively manage CAD for life.

Top investors

4% employee growth in 12 months

Our take

HeartFlow is a medical equipment manufacturer that uses CT-scanned 3D modelling to assess and analyze a patient's heart and arteries. This non-invasive process can help assess the risks of Coronary Artery Disease (CAD) and strategize the appropriate treatment.

As the world’s leading cause of death, CAD is a worthy target for improved diagnosis and treatment. HeartFlow's approach enables clinicians to deliver more effective treatments faster, making CAD more manageable than ever before.

The company has a long history of awards and innovations, adopting technological advancements as they happen. It successfully launched its IPO in 2021, although a 2022 merger with Longview Acquisitions was called off due to unfavourable market conditions. Despite this, the company remains steadfast, unveiling new technology that ensures better treatment for CAD patients.

Steph headshot

Steph

Company Specialist at Welcome to the Jungle

Benefits

  • Medical / Dental / Vision (90% of premium paid by Heartflow)
  • Flexible Spending and Health Savings Accounts
  • 401k plan with employer match
  • Company holidays
  • Paid sick time and vacation
  • Parental leave
  • EAP Program
  • Free snacks and drinks
  • Fitness competition, Blood drive, Waffle Wednesdays and more!

Funding (last 2 of 11 rounds)

Mar 2025

$98m

CONVERTIBLE

Apr 2023

$215m

SERIES F

Total funding: $980.6m

This company has top investors

Leadership

John Farquhar

(President & CEO)

Joined HeartFlow in 2021 as the President and Chief Operating Officer and became the CEO in 2022. Prior to this, they were the VP and General Manager at Medtronic. They also spent 5 years as a Professional Football Player in the NFL.